Bildkälla: Stockfoto

Analyst Group Comment on STENOCARE’s Product Approval in Germany

STENOCARE announced on May 25th, that a new medical cannabis oil product has received approval from the Federal Institute for Drugs and Medical Devices (BfArM) for prescription-based sales to German patients.

STENOCARE announced on May 25th, that a new medical cannabis oil product has received approval from the Federal Institute for Drugs and Medical Devices (BfArM) for prescription-based sales to German patients.
Börsvärldens nyhetsbrev
ANNONSER